Insights from 2023 ASH Annual Meeting
Video Player is loading.
10 seconds
Playback speed
ASH 2023 Insights: "A Study of Venetoclax Added to Ibrutinib to Eliminate Ibrutinib Resistance Mutations in CLL"
By
Insights from 2023 ASH Annual Meeting
FEATURING
Kerry Rogers
By
Insights from 2023 ASH Annual Meeting
FEATURING
Kerry Rogers
Comments 0
Login to view comments.
Click here to Login
